Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience.
Rastellini
C
C
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania 15213, USA.
Shapiro
R
R
Corry
R
R
Fung
J J
JJ
Starzl
T E
TE
Rao
A S
AS
D016026:Bone Marrow Transplantation; D002096:C-Peptide / Q000097:blood; D002469:Cell Separation / Q000379:methods; D046508:Culture Techniques / Q000379:methods; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000209:etiology / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology; D016381:Islets of Langerhans Transplantation / Q000379:methods / Q000401:mortality / Q000502:physiology*; D016030:Kidney Transplantation; D016031:Liver Transplantation; D010180:Pancreatectomy; D011169:Portal Vein; D015996:Survival Rate; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D002096:C-Peptide